Elorac, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Vernon Hills IL United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2014
NCT02251678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ELORAC